Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zainab Ashimiyu‐Abdusalam"'
Autor:
Oluwatosin Maryam Adeyemo, Zainab Ashimiyu‐Abdusalam, Mary Adewunmi, Temitope Ayanfunke Ayano, Muhammad Sohaib, Reem Abdel‐Salam
Publikováno v:
Cancer Reports, Vol 7, Iss 4, Pp n/a-n/a (2024)
Abstract Background NSCLC is a lethal cancer that is highly prevalent and accounts for 85% of cases of lung cancer. Conventional cancer treatments, such as chemotherapy and radiation, frequently exhibit limited efficacy and notable adverse reactions.
Externí odkaz:
https://doaj.org/article/6b4490819506444ab4e7375370691895
Autor:
Salimat O. Sofela, Damilola S. Bodun, Damilola A. Omoboyowa, Precious A. Ajiboro, Daniel O. Nwankwo, Zainab Ashimiyu-Abdusalam, Ibidun B. Issac, Buhari Abdulrasheed, Toheeb A. Balogun, Ifetayo H. Ajayi
Publikováno v:
Informatics in Medicine Unlocked, Vol 42, Iss , Pp 101368- (2023)
Gefitinib, an established anticancer medication targeting Epidermal Growth Factor Receptor (EGFR), has faced challenges due to tumor resistance and relapse over time. A notable factor in Gefitinib resistance is the elevated expression of FGFR2. Combi
Externí odkaz:
https://doaj.org/article/32b92400f4a64a8fbb4629f0fe3f21fc
Autor:
Adeyemo, Oluwatosin Maryam, Ashimiyu‐Abdusalam, Zainab, Adewunmi, Mary, Ayano, Temitope Ayanfunke, Sohaib, Muhammad, Abdel‐Salam, Reem
Publikováno v:
Cancer Reports; Apr2024, Vol. 7 Issue 4, p1-11, 11p
Publikováno v:
Cancer Weekly; 11/14/2023, p312-312, 1p